Health
Eli Lilly investors spooked by weak Mounjaro sales, but it’s the obesity drug approval that will unlock its value
The demand is there, but so are the hurdles. Eli Lilly investors got a reality check on Thursday, as the stock tumbled more than 6%. Hopes have been running high for the company’s recently launched Mounjaro. Right now, the drug has been approved to treat type 2 diabetes, but many expect sales to really take […]
Read More
Jim Cramer’s Investing Club meeting Thursday: Meta, Eli Lilly, Estee Lauder
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. Don’t sell Meta Look past Eli Lilly’s tough quarter Chance to buy Estee Lauder 1. Don’t sell Meta Shares of Meta Platforms (META) soared more than 25% Thursday morning, to […]
Read More
GOP attorneys general warn CVS, Walgreens against mailing abortion pill in their states
Mifepristone (Mifeprex) and Misoprostol, the two drugs used in a medication abortion, are seen at the Women’s Reproductive Clinic, which provides legal medication abortion services, in Santa Teresa, New Mexico, on June 17, 2022. Robyn Beck | AFP | Getty Images Republican attorneys general in 20 states warned CVS and Walgreens this week against mailing […]
Read More
The Covid pandemic drives Pfizer’s 2022 revenue to a record $100 billion
Empty vials of Pfizer-BioNTech coronavirus disease (COVID-19) children’s vaccines are pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., May 19, 2022. Hannah Beier | Reuters The ongoing Covid-19 pandemic propelled pharmaceutical company Pfizer’s earnings to a record $100 billion last year, almost $57 billion of which was driven by its vaccine and antiviral pill Paxlovid, […]
Read More
The end of the Covid health emergency won’t slow FDA clearance of shots and treatments
Vials and a medical syringe seen displayed in front of the Food and Drug Administration (FDA) of the United States logo. FDA finds the COVID-19 vaccine. Pavlo Gonchar | LightRocket | Getty Images The Food and Drug Administration on Tuesday said its emergency authorizations of Covid vaccines, tests and treatments will not be impacted by […]
Read More
Jim Cramer’s Investing Club meeting Tuesday: Caterpillar, J&J, Humana
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Opportunity to buy Caterpillar Confident in decision to buy Johnson & Johnson Why buy ahead of an overhang? 1. Opportunity to buy Caterpillar Shares of Caterpillar (CAT) were down 4.2% […]
Read More
Pfizer expects 2023 sales to decline as much as 33% compared with record-breaking 2022
Vials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3, 2022. Rodrigo Garrido | Reuters Pfizer on Tuesday issued sales guidance of $67 billion to $71 billion for 2023, a decline from its record-breaking 2022 results. The pharmaceutical company booked […]
Read More
Google’s ex-CEO Eric Schmidt tapped for federal biotech commission that allows members to keep biotech investments
On Dec. 30, leaders of the House and Senate Armed Services committees announced the selection of former Google CEO Eric Schmidt and 11 others to serve on a new federal commission on biotechnology. Tasked with reviewing the biotech industry and suggesting investments that would benefit U.S. security, the National Security Commission on Emerging Biotechnology is […]
Read More
Biden administration plans to end Covid public health emergency in May
U.S. President Joe Biden delivers remarks on the coronavirus disease (COVID-19) before receiving a second COVID-19 booster vaccination in the Eisenhower Executive Office Building’s South Court Auditorium at the White House in Washington, U.S., March 30, 2022. Kevin Lamarque | Reuters The Biden administration plans to end the Covid public health emergency this spring, as […]
Read More
Obamacare enrollment to open this spring for people losing Medicaid after pandemic protections end
Millions of people in the U.S. are at risk of losing Medicaid this year when coverage protections put in place during the Covid-19 pandemic come to an end in April. To make it easier for these individuals to transition to other coverage, the Health and Human Services Department has announced a special enrollment period for […]
Read More